Cyclic AMP level of lymphocytes in patients with systemic lupus erythematosus and its relation to disease activity
- 14 November 1989
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 23 (1) , 61-64
- https://doi.org/10.1016/0165-2478(89)90156-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune responseImmunology Today, 1988
- Inhibition of adenylate cyclase by IL 2 in human T lymphocytes is mediated by protein kinase CBiochemical and Biophysical Research Communications, 1987
- Elevation of cyclic 3′5′ adenosine monophosphate levels by cholera toxin inhibits the generation of interleukin 2 activityCellular Immunology, 1986
- Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells.Journal of Clinical Investigation, 1985
- Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosusClinical Immunology and Immunopathology, 1984
- Impaired natural killer cell function in systemic lupus erythematosusArthritis & Rheumatism, 1983
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1982
- Prostaglandin E inhibits the production of human interleukin 2.The Journal of Experimental Medicine, 1982
- Studies on the cyclic AMP response to prostaglandin in human lymphocytesCellular Immunology, 1981